ENTA
Price
$7.76
Change
+$0.11 (+1.44%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
165.67M
33 days until earnings call
PLRX
Price
$1.19
Change
+$0.01 (+0.85%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
73.05M
34 days until earnings call
Interact to see
Advertisement

ENTA vs PLRX

Header iconENTA vs PLRX Comparison
Open Charts ENTA vs PLRXBanner chart's image
Enanta Pharmaceuticals
Price$7.76
Change+$0.11 (+1.44%)
Volume$6.88K
Capitalization165.67M
Pliant Therapeutics
Price$1.19
Change+$0.01 (+0.85%)
Volume$51.38K
Capitalization73.05M
ENTA vs PLRX Comparison Chart in %
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTA vs. PLRX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a StrongBuy and PLRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (ENTA: $7.75 vs. PLRX: $1.19)
Brand notoriety: ENTA and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 75% vs. PLRX: 121%
Market capitalization -- ENTA: $165.67M vs. PLRX: $73.05M
ENTA [@Biotechnology] is valued at $165.67M. PLRX’s [@Biotechnology] market capitalization is $73.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTA is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 3 TA indicator(s) are bullish while PLRX’s TA Score has 3 bullish TA indicator(s).

  • ENTA’s TA Score: 3 bullish, 5 bearish.
  • PLRX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ENTA is a better buy in the short-term than PLRX.

Price Growth

ENTA (@Biotechnology) experienced а +0.65% price change this week, while PLRX (@Biotechnology) price change was +1.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

ENTA is expected to report earnings on Nov 24, 2025.

PLRX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($166M) has a higher market cap than PLRX($73M). ENTA YTD gains are higher at: 34.783 vs. PLRX (-91.040). ENTA has higher annual earnings (EBITDA): -87.12M vs. PLRX (-214.08M). PLRX has more cash in the bank: 306M vs. ENTA (193M). ENTA (58.7M) and PLRX (60.2M) have identical debt. ENTA has higher revenues than PLRX: ENTA (64.5M) vs PLRX (0).
ENTAPLRXENTA / PLRX
Capitalization166M73M227%
EBITDA-87.12M-214.08M41%
Gain YTD34.783-91.040-38%
P/E RatioN/AN/A-
Revenue64.5M0-
Total Cash193M306M63%
Total Debt58.7M60.2M98%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTAPLRX
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
70%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 6 days ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIBH28.67N/A
N/A
First Bancshares, Inc.
ZEOOF9.35N/A
N/A
Zeon Corp.
BECEF13.10N/A
N/A
BCE Inc.
CHEOY97.52-1.57
-1.58%
CochLear Ltd.
ECRTF1.60-0.29
-15.34%
Atex Resources Inc.

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ALEC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+1.31%
ALEC - ENTA
43%
Loosely correlated
+5.56%
BEAM - ENTA
40%
Loosely correlated
+5.84%
SCPH - ENTA
39%
Loosely correlated
+2.59%
ADCT - ENTA
39%
Loosely correlated
+6.30%
PRME - ENTA
38%
Loosely correlated
+7.89%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with ITRM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then ITRM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-6.35%
ITRM - PLRX
41%
Loosely correlated
-4.17%
SRRK - PLRX
41%
Loosely correlated
-1.42%
LXRX - PLRX
41%
Loosely correlated
-3.13%
FHTX - PLRX
40%
Loosely correlated
-6.82%
OCUL - PLRX
40%
Loosely correlated
-0.10%
More